These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7110144)

  • 21. Protection against lethal influenza with neuraminidase.
    Webster RG; Reay PA; Laver WG
    Virology; 1988 May; 164(1):230-7. PubMed ID: 2452514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus.
    Baker AT; Varghese JN; Laver WG; Air GM; Colman PM
    Proteins; 1987; 2(2):111-7. PubMed ID: 3447170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza A virus enhances IgE-mediated histamine release from human basophil leukocytes. Examination of the effect of viral neuraminidase and haemagglutinin.
    Clementsen P; Douglas AR; Skehel JJ; Hannoun C; Bach-Mortensen N; Norn S
    Agents Actions; 1989 Apr; 27(1-2):58-61. PubMed ID: 2473634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steps in maturation of influenza A virus neuraminidase.
    Saito T; Taylor G; Webster RG
    J Virol; 1995 Aug; 69(8):5011-7. PubMed ID: 7541844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperative neuraminidase activity in a paramyxovirus.
    Mahon PJ; Deng R; Mirza AM; Iorio RM
    Virology; 1995 Oct; 213(1):241-4. PubMed ID: 7483268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Affinity ranking of influenza neuraminidase mutants with monoclonal antibodies using an optical biosensor. Comparison with ELISA and slot blot assays.
    Gruen LC; McKimm-Breschkin JL; Caldwell JB; Nice EC
    J Immunol Methods; 1994 Jan; 168(1):91-100. PubMed ID: 8288899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic studies on the sialidase of three influenza B and three influenza A virus strains.
    Cabezas JA; Milicua M; Bernal CS; Villar E; Perez N; Hannoun C
    Glycoconj J; 1989; 6(2):219-27. PubMed ID: 2535486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of influenza A neuraminidase (subtype N1) potency by ELISA.
    Wan H; Sultana I; Couzens LK; Mindaye S; Eichelberger MC
    J Virol Methods; 2017 Jun; 244():23-28. PubMed ID: 28257802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Difficulties in standardizing the neuraminidase content of influenza vaccines.
    Gérentes L; Kessler N; Aymard M
    Dev Biol Stand; 1999; 98():189-96; discussion 197. PubMed ID: 10494973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human sera possess a limited antibody repertoire to influenza neuraminidase antigenic variants selected in vitro.
    Natali A; Panizzi PF; Chezzi C; Oxford JS
    J Hyg (Lond); 1984 Apr; 92(2):243-50. PubMed ID: 6707473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates.
    Lambré CR; Terzidis H; Greffard A; Webster RG
    J Immunol Methods; 1990 Dec; 135(1-2):49-57. PubMed ID: 1703190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
    Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.
    Wan H; Qi L; Gao J; Couzens LK; Jiang L; Gao Y; Sheng ZM; Fong S; Hahn M; Khurana S; Taubenberger JK; Eichelberger MC
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence of the neuraminidase gene of influenza virus A/Tokyo/3/67 and previously uncharacterized monoclonal variants.
    Lentz MR; Air GM; Laver WG; Webster RG
    Virology; 1984 May; 135(1):257-65. PubMed ID: 6203216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influenza virus sialidase: effect of calcium on steady-state kinetic parameters.
    Chong AK; Pegg MS; von Itzstein M
    Biochim Biophys Acta; 1991 Mar; 1077(1):65-71. PubMed ID: 2009295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological and protective properties of immune sera directed to the influenza virus neuraminidase.
    Halbherr SJ; Ludersdorfer TH; Ricklin M; Locher S; Berger Rentsch M; Summerfield A; Zimmer G
    J Virol; 2015 Feb; 89(3):1550-63. PubMed ID: 25392225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Action of influenza virus neuraminidase on gangliosides. Haemagglutinin inhibits viral neuraminidase.
    Slepushkin VA; Bukrinskaya AG; Prokazova NV; Zhigis LS; Reshetov PD; Shaposhnikova JI; Bergelson LD
    FEBS Lett; 1985 Mar; 182(2):273-7. PubMed ID: 3979549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antigenic specificity of neuraminidase and structure of neuraminidase gene of influenza A(H1N1) serotype Hsw1N1 viruses isolated from man and animals].
    Chuvakova ZK; Dem'ianenko IV; Chaĭka OV; Shilov AA; Kim EV; Rovnova ZI; Isaeva EI; Isaeva ES
    Vopr Virusol; 1989; 34(6):656-61. PubMed ID: 2483778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza A neuraminidase antibodies in children and young adults studied by serum absorption.
    Callow KA; Beare AS
    J Hyg (Lond); 1977 Apr; 78(2):213-22. PubMed ID: 265343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus.
    Kida H; Webster RG; Yanagawa R
    Arch Virol; 1983; 76(2):91-9. PubMed ID: 6191738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.